Scalable syntheses of (2S, 3S)-3-N-tert-butoxycarbonylamino-2-hydroxy-4-phenylbutanoic acid (BocAHPBA) 1 and (R)-3-tert-butoxycarbonyl-5, 5-dimethyl-1, 3-thiazolidine-4- carboxylic acid (BocDMTA) 2 have been developed. Both 1 and 2 can serve as chiral building blocks in assembling JE-2147 (KNI-764) 3, a potent HIV protease inhibitor. The synthesis of (2S, 3S)-BocAHPBA 1 is achieved in 41% overall yield from (S)-2-N, N- ...